ASTON SCI Trademark

Trademark Overview


On Tuesday, May 30, 2023, a trademark application was filed for ASTON SCI with the United States Patent and Trademark Office. The USPTO has given the ASTON SCI trademark a serial number of 98018774. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, January 8, 2025. This trademark is owned by ASTON Sci. Inc.. The ASTON SCI trademark is filed in the Pharmaceutical Products category with the following description:

Pituitary hormone preparations; pharmaceutical preparations for immunity adjustment; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; biochemical preparations for the treatment of tumor and immunologic diseases; cells for medical purposes; blood for medical purposes; chemical preparations for the treatment of tumor and immunologic diseases; human plasma protein; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumor and immunologic diseases; pharmaceutical preparations acting on the central nervous system; tumor suppressing agents
aston sci

General Information


Serial Number98018774
Word MarkASTON SCI
Filing DateTuesday, May 30, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, January 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements


Goods and ServicesPituitary hormone preparations; pharmaceutical preparations for immunity adjustment; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; biochemical preparations for the treatment of tumor and immunologic diseases; cells for medical purposes; blood for medical purposes; chemical preparations for the treatment of tumor and immunologic diseases; human plasma protein; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumor and immunologic diseases; pharmaceutical preparations acting on the central nervous system; tumor suppressing agents
NOT AVAILABLE"SCI"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 7, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameASTON Sci. Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 12925
KR

Trademark Events


Event DateEvent Description
Friday, June 2, 2023NEW APPLICATION ENTERED
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 21, 2024ASSIGNED TO EXAMINER
Thursday, February 22, 2024NON-FINAL ACTION WRITTEN
Thursday, February 22, 2024NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 17, 2024SUSPENSION LETTER WRITTEN
Wednesday, April 17, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 17, 2024LETTER OF SUSPENSION E-MAILED
Monday, December 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 6, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 6, 2025EXAMINERS AMENDMENT E-MAILED
Monday, January 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 6, 2025EXAMINER'S AMENDMENT ENTERED
Monday, January 6, 2025EXAMINERS AMENDMENT -WRITTEN